Trial Outcomes & Findings for Effects of The Pregnant Follow-Up Conducted With Home Visits on The Perinatal Outcomes (NCT NCT04628598)

NCT ID: NCT04628598

Last Updated: 2026-04-08

Results Overview

Perinatal Information Form is a form consisting of a total of 35 questions in which data on the participants' knowledge about pregnancy, birth and postnatal process were collected. Kuder Richardson reliability method was used to translate the data of the Perinatal Information Form into scoring. A reliability coefficient of 0.80 and above is recommended (Bademci, 2011). This form was used twice in the study as pre-test and post-test. The reliability coefficient of the Perinatal Information Form was 0.83 for the pretest and 0.87 for the posttest. The 35 questions on the form assess the level of knowledge about pregnancy, childbirth and the postnatal period and are scored as correct or incorrect (0.1) (the average ratio reflects the number of items answered correctly or incorrectly by participants). The highest possible score on the questionnaire is 35 and the lowest is 0.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

64 participants

Primary outcome timeframe

"assessed pre-test (baseline) and post-test (13 weeks), week 13 reported"

Results posted on

2026-04-08

Participant Flow

On November 2, 2020, primiparous pregnant women registered in the family health center in Kadıköy, Istanbul, were randomly assigned to the intervention and control groups using a simple random method. The first group formed the intervention group. The pregnant women in the list corresponding to the randomly assigned numbers were assigned to the intervention and control groups.

The study population consisted of 433 pregnant women in the appropriate first trimester. The 433 pregnant women in the universe were listed and numbered in an Excel spreadsheet. From the random.org site, 64 pregnant women were listed in number order as 2 unique groups. 64 pregnant women were included in the study as 32 intervention and 32 control.

Participant milestones

Participant milestones
Measure
Home Visiting Pregnant Women (Intervention Group)
The pregnant women in the experimental group will be given education and care with home visits. Antenatal care and prenatal education with a home visit: Providing prenatal education and care by home visits to pregnant women
Control Group
Home visits will not be made to the control group, only the primary care antenatal care will be followed.
Overall Study
STARTED
32
32
Overall Study
COMPLETED
26
28
Overall Study
NOT COMPLETED
6
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Home Visiting Pregnant Women (Intervention Group)
The pregnant women in the experimental group will be given education and care with home visits. Antenatal care and prenatal education with a home visit: Providing prenatal education and care by home visits to pregnant women
Control Group
Home visits will not be made to the control group, only the primary care antenatal care will be followed.
Overall Study
Lost to Follow-up
3
2
Overall Study
Protocol Violation
3
2

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Home Visiting Pregnant Women (Intervention Group)
n=26 Participants
The pregnant women in the experimental group will be given education and care with home visits. Antenatal care and prenatal education with a home visit: Providing prenatal education and care by home visits to pregnant women
Control Group
n=28 Participants
Home visits will not be made to the control group, only the primary care antenatal care will be followed.
Total
n=54 Participants
Total of all reporting groups
Age, Continuous
30.65 Year
STANDARD_DEVIATION 4.55 • n=26 Participants
32.53 Year
STANDARD_DEVIATION 4.27 • n=28 Participants
31.62 Year
STANDARD_DEVIATION 4.46 • n=54 Participants
Sex: Female, Male
Female
26 Participants
n=26 Participants
28 Participants
n=28 Participants
54 Participants
n=54 Participants
Sex: Female, Male
Male
0 Participants
n=26 Participants
0 Participants
n=28 Participants
0 Participants
n=54 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.

PRIMARY outcome

Timeframe: "assessed pre-test (baseline) and post-test (13 weeks), week 13 reported"

Population: İntervention Group and Control Group

Perinatal Information Form is a form consisting of a total of 35 questions in which data on the participants' knowledge about pregnancy, birth and postnatal process were collected. Kuder Richardson reliability method was used to translate the data of the Perinatal Information Form into scoring. A reliability coefficient of 0.80 and above is recommended (Bademci, 2011). This form was used twice in the study as pre-test and post-test. The reliability coefficient of the Perinatal Information Form was 0.83 for the pretest and 0.87 for the posttest. The 35 questions on the form assess the level of knowledge about pregnancy, childbirth and the postnatal period and are scored as correct or incorrect (0.1) (the average ratio reflects the number of items answered correctly or incorrectly by participants). The highest possible score on the questionnaire is 35 and the lowest is 0.

Outcome measures

Outcome measures
Measure
Home Visiting Pregnant Women
n=26 Participants
The pregnant women in the experimental group will be given education and care with home visits. Antenatal care and prenatal education with a home visit: Providing prenatal education and care by home visits to pregnant women
Control Group
n=28 Participants
Home visits will not be made to the control group, only the primary care antenatal care will be followed.
Prenatal Education Knowledge Rate
Total correct
29.61 questions
Standard Deviation 5.72
21.64 questions
Standard Deviation 3.66
Prenatal Education Knowledge Rate
Total wrong
5.38 questions
Standard Deviation 0.23
13.35 questions
Standard Deviation 1.86

PRIMARY outcome

Timeframe: Thirty (30) weeks

Population: Percentage of participants' birth patterns

After the home visits of pregnant women, a questionnaire will be applied in the postpartum period and delivery methods will be asked.

Outcome measures

Outcome measures
Measure
Home Visiting Pregnant Women
n=26 Participants
The pregnant women in the experimental group will be given education and care with home visits. Antenatal care and prenatal education with a home visit: Providing prenatal education and care by home visits to pregnant women
Control Group
n=28 Participants
Home visits will not be made to the control group, only the primary care antenatal care will be followed.
Spontaneous Vaginal Birth Rate
Vaginal Birth
7 Participants
6 Participants
Spontaneous Vaginal Birth Rate
Cesarean Section
19 Participants
22 Participants

PRIMARY outcome

Timeframe: Thirty (30) weeks

Population: Breastfeeding Self-Efficacy Scale Mean Score

Breastfeeding Self-Efficacy Scale will be applied to look at the effect of breastfeeding training in the postpartum period during home visits during pregnancy. Breastfeeding Self-Efficacy Scale; Breastfeeding Self-Efficacy Scale is a 33-item scale developed by Dennis in 1999. It was first applied to 130 English-speaking Canadian women, the Cronbach alpha value was found to be 0.96, and the item-total correlation of 73% of the items was 0.30-0.70. He then developed the Brief Breastfeeding Self-Efficacy Scale by reducing the scale to a 14-item scale in 2003. Cronbach alpha value was found to be 0.94. Breastfeeding Self-Efficacy Short Form Scale is a 5-point Likert Type scale 1 = "Not sure at all" and 5 = "I'm always sure". As suggested by Bandura (1998), all items are in positive direction. The minimum score that can be obtained from the scale is 14 maximum 70. High score is an indicator of high breastfeeding self-efficacy.

Outcome measures

Outcome measures
Measure
Home Visiting Pregnant Women
n=26 Participants
The pregnant women in the experimental group will be given education and care with home visits. Antenatal care and prenatal education with a home visit: Providing prenatal education and care by home visits to pregnant women
Control Group
n=28 Participants
Home visits will not be made to the control group, only the primary care antenatal care will be followed.
Breastfeeding Self-efficacy
52.80 score on a scale
Standard Deviation 7.63
52.14 score on a scale
Standard Deviation 10.38

PRIMARY outcome

Timeframe: Thirty (30) weeks

Population: Edinburgh Postpartum Depression Scale Score Average

Edinburgh Postpartum Depression Scale will be applied to examine the effect of home visits and prenatal education on postpartum depression. Edinburgh Postpartum Depression Scale (EPDS); EPDS is a 4-point Likert style self-report scale consisting of 10 items. PRES was adapted to Turkish by Engindeniz. In Engindeniz's validity and reliability study, this scale had an internal consistency coefficient of 0.79, a split-half reliability, a cut-off of 0.80 of 12/13, a sensitivity of 0.84, a specificity of 0.88, a positive predictive value of 0.69, and a negative predictive value of 0.94. The Edinburgh Postnatal Depression Scale is a 10-item self-report scale assessing the common symptoms of depression. Each item is scored on a 4 point scale (O-3), the minimum and maximum total score ranging from O-30, respec- tively. The highest score is 30 points. If it is less than 9 points, there is no risk for depression, if it is 13 and above, there is a high risk for depression.

Outcome measures

Outcome measures
Measure
Home Visiting Pregnant Women
n=26 Participants
The pregnant women in the experimental group will be given education and care with home visits. Antenatal care and prenatal education with a home visit: Providing prenatal education and care by home visits to pregnant women
Control Group
n=28 Participants
Home visits will not be made to the control group, only the primary care antenatal care will be followed.
Postpartum Depression
8.76 score on a scale
Standard Deviation 5.46
7.35 score on a scale
Standard Deviation 4.27

Adverse Events

Home Visiting Pregnant Women (Intervention Group)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Ayça Demir Yıldırım

İstanbul Üniversitesi Cerrahpaşa

Phone: +905066603355

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place